Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone

American Journal of Cardiology

Volumn 108, Issue 5, 2011, Pages 705-710

  Jackevicius, Cynthia Anne ^a,b,c,d   Tom, Albert ^a   Essebag, Vidal ^e   Eisenberg, Mark J ^e   Rahme, Elham ^e   Tu, Jack Ven ^b,c   Humphries, Karin ^f   Behlouli, Hassan ^e   Pilote, Louise ^e  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

AGED; ARTICLE; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA BASE; DRUG MEGADOSE; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LOW DRUG DOSE; LUNG FIBROSIS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; PROPORTIONAL HAZARDS MODELS; PULMONARY FIBROSIS; QUEBEC; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80051788128     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.04.024     Document Type: Article

References (30)

1. Amiodarone Trialists' Meta-Analysis Investigators Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials Lancet 350 2007 1417 1424
2. J.W. Mason Amiodarone N Engl J Med 316 1987 455 466 (Pubitemid 17035573)
3. W.J. Martin, and E.C. Rosenow Amiodarone pulmonary toxicity Recognition and pathogenesis (part I) Chest 93 1988 1067 1075
4. H.H. Rotmensch, M. Liron, M. Tupilski, and S. Laniado Possible association of pneumonitis with amiodarone therapy Am Heart J 100 1980 412 413 (Pubitemid 11226217)
5. V.R. Vorperian, T.C. Havighurst, S. Miller, and C.T. January Adverse effects of low dose amiodarone: a meta-analysis J Am Coll Cardiol 30 1997 791 798
6. J.E. Tisdale, S.L. Follin, A. Ordelova, and C.R. Webb Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone J Clin Pharmacol 35 1995 351 356
7. B. Olshansky, M. Sami, A. Rubin, J. Kostis, S. Shorofsky, A. Slee, H.L. Greene NHLBI AFFIRM Investigators Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study Am J Cardiol 95 2005 404 405 (Pubitemid 40164550)
8. R.E. Dusman, M.S. Stanton, W.M. Miles, L.S. Klein, D.P. Zipes, N.S. Fineberg, and J.J. Heger Clinical features of amiodarone-induced pulmonary toxicity Circulation 82 1990 51 59 (Pubitemid 20216315)
9. N.Z. Kerin, E. Aragon, K. Faitel, H. Frumin, and M. Rubenfire Long-term efficacy and toxicity of high- and low-dose amiodarone regimens J Clin Pharmacol 29 1989 418 423 (Pubitemid 19143599)
10. S.A. Magro, E.C. Lawrence, S.H. Wheeler, J. Krafchek, H.T. Lin, and C.R. Wyndham Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests J Am Coll Cardiol 12 1988 781 788
11. J.A. Cairns, S.J. Connolly, R. Roberts, and M. Gent Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators Lancet 349 1997 675 682 (Pubitemid 27107745)
12. Greene HL for the CASCADE Investigators The CASCADE study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle CASCADE Investigators Am J Cardiol 72 suppl 1993 70F 74F
13. H.C. Doval, D.R. Nul, H.O. Grancelli, S.V. Perrone, G.R. Bortman, and R. Curiel Randomised trial of low-dose amiodarone in severe congestive heart failure Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet 344 1994 493 498
14. Y. Yamada, T. Shiga, N. Matsuda, N. Hagiwara, and H. Kasanuki Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone Circ J 71 2007 1610 1616 (Pubitemid 47529665)
15. L. Rakita, S.M. Sobol, N. Mostow, and T. Vrobel Amiodarone pulmonary toxicity Am Heart J 106 1983 906 916 (Pubitemid 13010825)
16. J.I. Kennedy, J.L. Myers, V.J. Plumb, and J.D. Fulmer Amiodarone pulmonary toxicity Clinical, radiologic, and pathologic correlations Arch Intern Med 147 1987 50 55 (Pubitemid 17010759)
17. H. Ashrafian, and P. Davey Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 120 2001 275 282 (Pubitemid 32744890)
18. S.M. Sobol, and L. Rakita Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug Circulation 65 1982 819 824 (Pubitemid 12133250)
19. J.L. Myers, J.I. Kennedy, and V.J. Plumb Amiodarone lung: pathologic findings in clinically toxic patients Hum Pathol 18 1987 349 354 (Pubitemid 17071032)
20. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 2006 810 816 (Pubitemid 44511663)
21. B.N. Singh, S.N. Singh, D.J. Reda, X.C. Tang, B. Lopez, C.L. Harris, R.D. Fletcher, S.C. Sharma, J.E. Atwood, A.K. Jacobson, H.D. Lewis Jr, D.W. Raisch, M.D. Ezekowitz Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators Pulmonary effect of amiodarone in patients with heart failure J Am Coll Cardiol 30 1997 514 517 (Pubitemid 27339333)
22. A.J. Greenspon, G.A. Kidwell, W. Hurley, and J. Mannion Amiodarone-related postoperative adult respiratory distress syndrome Circulation 84 suppl III 1991 III-407 III-415
23. W. Van Mieghem, L. Coolen, I. Malysse, L.M. Lacquet, G.J. Deneffe, and M.G. Demedts Amiodarone and the development of ARDS after lung surgery Chest 105 1994 1642 1645 (Pubitemid 24180643)
24. Cordarone (Amiodarone) Prescribing Information 2008 Sanofi Winthrop Industrie Ambares, France
25. A.W. Dreisbach, and J.J. Lertora The effect of chronic renal failure on hepatic drug metabolism and drug disposition Semin Dial 16 2003 45 50 (Pubitemid 37356766)
26. N. Goldschlager, A.E. Epstein, G. Naccarelli, B. Olshansky, and B. Singh Practical guidelines for clinicians who treat patients with amiodarone Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology Arch Intern Med 160 2000 1741 1748
27. B.N. Singh, S.N. Singh, D.J. Reda, X.C. Tang, B. Lopez, C.L. Harris, R.D. Fletcher, S.C. Sharma, J.E. Atwood, A.K. Jacobson, H.D. Lewis Jr, D.W. Raisch, and M.D. Ezekowitz Amiodarone versus sotalol for atrial fibrillation N Engl J Med 352 2005 1861 1872
28. Sanofi-Aventis DIONYSOS study results showed the respective profiles of dronedarone and amiodarone http://en.sanofi-aventis.com/binaries/20081223- dionysos-fe-en-en-tcm28-23624.pdf December 23 2008 Accessed on December 28, 2009
29. J.P. Piccini, V. Hasselblad, E.D. Peterson, J.B. Washam, R.M. Califf, and D.F. Kong Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation J Am Coll Cardiol 54 2009 1089 1095
30. Multaq® (Dronedarone) Prescribing Information 2009 Sanofi Winthrop Industrie Ambares, France http://products.sanofi-aventis.us/multaq/multaq.pdf Accessed on December 28, 2009